HIC
CLB icon

Harvey Investment Company’s Core Laboratories CLB Stock Holding History

Harvey Investment Company’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-34,270
Closed -$3.85M – 78
2016
Q1 		$3.85M Sell
34,270
-3,400
-9% -$353K 0.86% 36
2015
Q4 		$4.1M Sell
37,670
-4,450
-11% -$509K 0.94% 32
2015
Q3 		$4.21M Hold
42,120
– – 1.01% 32
2015
Q2 		$4.8M Hold
42,120
– – 1.12% 31
2015
Q1 		$4.4M Buy
42,120
+37,120
+742% +$3.95M 1.05% 32
2014
Q4 		$603K Buy
+5,000
New +$657K 0.14% 63

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Harvey Investment Company's CLB Position: Q2 2016 in Review

Harvey Investment Company sold out of Core Laboratories (CLB) in Q2 2016, closing a stake of 34,270 shares — an estimated $3.85M sold.

Harvey Investment Company first reported a position in CLB in Q4 2014 and held it in 6 quarters. The position peaked at $4.8M in Q2 2015. 384 funds tracked by Wall St. Rank hold CLB as of Q2 2016.

  • Harvey Investment Company reported no remaining Core Laboratories position as of Q2 2016 after selling out during the quarter.
  • Harvey Investment Company sold 34,270 Core Laboratories shares in Q2 2016, an estimated $3.85M.
  • Harvey Investment Company first reported a position in Core Laboratories in Q4 2014 and held it in 6 quarters.
  • Harvey Investment Company's Core Laboratories position peaked at $4.8M in Q2 2015.
  • 384 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2016.

Based on Harvey Investment Company's 13F filing for Q2 2016, filed 28 Jul 2016.